Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants | Signal Transduction and Targeted Therapy
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Guideline Therapeutics and COVID-19: living guideline
REVISTA ESPAÑOLA DE
NORTH SAILS 603154 - Parka
Antioxidants | Free Full-Text | The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
EL VALOR DEL MEDICAMENTO DESDE UNA PERSPECTIVA SOCIAL
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement | Science
XXXVII Congreso SETH 2021.indd
XXXVII Congreso SETH 2021.indd
NAPAPIJRI Rainforest Winter - Jacket
MADS NØRGAARD – COPENHAGEN – MADS NØRGAARD - COPENHAGEN
Pre-existing Reactivity to an IgG4 Fc-Epitope: Characterization and Mitigation of Interference in a Bridging Anti-drug Antibody Assay | SpringerLink
XXXVII Congreso SETH 2021.indd
Frontiers | Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention
Guideline Therapeutics and COVID-19: living guideline
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
Comunicaciones orales
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo | Science Advances
